TrialEuropean heart journal2019

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.

Jonas Oldgren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.